At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Rutgers Startup Seeks to Tap the Power of AI to Become the First Commercial “Self-Driving Lab”.
- The 10 Popular Health Trends You Shouldn’t Try in 2025.
- New NJACTS Publication
- Tech Can Help People Living with Dementia to Help Themselves, NJIT Expert Says.
- Heart disease is killing Black women; 5 tips for preventing it.
Categories
- Community (2,185)
- Covid (983)
- CTO Events (6)
- News (2,791)
- Pilots (21)